ÂÜÀòÂÒÂ×

Frank Rutsch is currently a member of the Clinical Advisory Board at Inozyme Pharma. Frank was previously the Head of Rare Renal and Musculoskeletal Diseases Research at Sanofi Genzyme from April 2015 to October 2020. Prior to that, they were a Principal Scientist/Associate Director at Genzyme, A Sanofi Company from April 2010 to March 2015, where they directed scientific activities of ~40 FTEs across multiple functional groups. Frank has also served as an Instructor in Medicine at Massachusetts General Hospital/ Harvard Medical School from September 2005 to November 2005, and as a Staff II Scientist at Genzyme Corporation from November 2005 to March 2010.

Frank Rutsch has a PhD in Biology from McGill University, an MSc in Microbiology and Immunology from Université Laval, and a B.Sc. in Biochemistry from McGill University.